Self-Monitoring of Transcutaneous Bilirubinometry in Healthy Term and Near-Term Neonates: a Multi-center Prospective Study
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 220,950
- 试验地点
- 1
- 主要终点
- Development of TcB Nomogram in Term and Late-preterm Infants from birth to 30 days of age
研究概览
简要总结
The goal of this observational study is to monitor the transcutaneous bilirubin (TCB) level in healthy near-term and full-term neonates from birth to 30 days of age across China. The main question it aims to answer is:
Development of TcB Nomogram to Identify Neonatal Hyperbilirubinemia in Term and Late-preterm Infants Compare the changing trend of TCB among different areas in China Compare the changing trend of TCB among different gestational groups in China
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 0 Days 至 30 Days（Child）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Gestational age >=35wk; did not admitted to hospital for any reason Less than 30 days of age
排除标准
- •Accept phototherapy within 60h of age
结局指标
主要结局
Development of TcB Nomogram in Term and Late-preterm Infants from birth to 30 days of age
时间窗: through study completion, an average of 1 year
From birth to 7 days of age, newborns should undergo transcutaneous bilirubin monitoring twice daily. From 8 to 14 days of age, jaundice should be monitored once daily, and from 14 to 30 days of age, monitoring should be done at least once every two days.
次要结局
未报告次要终点